BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,084 | -19.0% | 380 | +1.9% | 0.00% | -33.3% |
| Q2 2023 | $23,574 | +66.9% | 373 | +18.8% | 0.00% | +50.0% |
| Q1 2023 | $14,127 | +158.0% | 314 | +151.2% | 0.00% | +100.0% |
| Q4 2022 | $5,476 | -71.2% | 125 | -57.6% | 0.00% | -66.7% |
| Q3 2022 | $19,000 | +26.7% | 295 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $15,000 | -25.0% | 295 | -4.2% | 0.00% | -33.3% |
| Q1 2022 | $20,000 | -80.6% | 308 | -67.8% | 0.00% | -81.2% |
| Q4 2021 | $103,000 | – | 957 | +95600.0% | 0.02% | – |
| Q3 2021 | $0 | -100.0% | 1 | -95.8% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 24 | +4.3% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 23 | +53.3% | 0.00% | – |
| Q4 2020 | $2,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |